- PharmaDrug (PHRX) announces the appointment of an auditor
- In accordance with National Instrument 51-102, the Notice of Change of Auditor, together with the required letter from the Former Auditor and the Successor Auditor have been reviewed by the company’s Audie Committee
- PharmaDrug also owns 100 per cent of Super Smart, a Dutch company building a modern adult-use psychedelic retail business with an elevated and educational focus
- PharmaDrug Inc. (PHRX) is up 8.33 per cent and is trading C$0.65 at 2:15 pm ET
PharmaDrug Inc. (PHRX) has appointed Harbourside CPA, LLP as the company’s auditor effective August 6, 2021.
The Notice of Change of Auditor, together with the required letter from the former auditor and the successor auditor, have been reviewed by the company’s Audit Committee.
PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs.
The company owns 80 per cent of Pharmadrug Production GmbH, a German medical cannabis distributor, with a Schedule I European Union narcotics license and German EuGMP certification allowing for the importation and distribution of medical cannabis to pharmacies in Germany and throughout the EU.
It also owns 100 per cent of Super Smart, a Dutch company building a modern adult-use psychedelic retail business with an elevated and educational focus.
PharmaDrug recently acquired Sairiyo Therapeutics, a biotech company that specializes in researching and reformulating established natural medicines with the goal of bringing them through regulatory and research-driven clinical trials.
PharmaDrug Inc. (PHRX) is up 8.33 per cent and is trading C$0.65 at 2:15 pm ET.
